. Transient transfections were performed as previously described Xie et al., 2004) . In brief, cells were transiently cotransfected with 1 µg of the appropriate reporter plasmid DNA and 0.1 µg of pRL-TK in 12-well plates using extruded DOTAP:cholesterol liposomes to evaluate promoter activities. To determine the in vivo killing effects, a panel of cell lines were transiently cotransfected with 2 µg of pUK21-CMV-BikDD, pUK21-C-VISA-BikDD or pUK21-C-VISA (negative control) plus 0.1 µg of pGL3-CMV-Luc.
Stable Cell Lines Expressing Firefly Luciferase
Panc02 and AsPC-1 cells were transfected with pEF1a-Luc-Neo (unpublished data) and selected with G418 (Invitrogen). G418-resistant clones, designated as Panc02-Luc and AsPC-1-Luc, were collected, identified, and maintained.
Animal Models of Pancreatic Cancer and Delivery of Plasmid DNA
Athymic female BALB/c nu/nu mice and female C57BL/6 mice (Charles River Laboratories, Wilmington, MA), at 6-8 weeks of age, were used as hosts for human xenograft tumors and mouse syngeneic tumors, respectively. Mice were maintained in a specific pathogen-free environment in compliance with institutional policy, and all animal procedures were previously approved by the appropriate institutional review boards. Plasmids were amplified in the DH5α strain of Escherichia coli and purified with an Endo-free Mega Prep Kit (Qiagen, Valencia, CA) in accordance with manufacturer's instructions. Plasmid DNA was dissolved in endotoxin-free TE buffer and was quantified by spectrophotometry at an optical density of 260 nm; it was free of major protein and RNA contamination, with an A260/A280 ratio of between 1.8 and 2.0. The amount of endotoxin present was determined by a chromogenic Limulus amoebocyte clotting assay (QCL-1000 kit; BioWhittaker, Walkersville, MD) and values were < 10 endotoxin units/mg of DNA (Loisel et al., 2001; Tousignant et al., 2003) . Plasmid DNA/extruded DOTAP:cholesterol complexes were prepared as described elsewhere (Chen et al., 2004; Day et al., 2006; Templeton et al., 1997) .
To test the specificity and activity of the promoters in vivo, we established both subcutaneous and orthotopic tumor models as follows. For the subcutaneous model, suspensions To test the antitumor effects of C-VISA-and CMV-driven BikDD in vivo, we established orthotopic models of Panc02-Luc and AsPC-1-Luc, Colo357FG, and Colo357L3.6pl cells. Each mouse was inoculated with a suspension of cells into the tail of the pancreas. After inoculation of cells, the mice were imaged with the IVIS system (or the tumors were measured by tumor weight, see below) and were randomly assigned to one of three groups; the groups received intravenous injections of 100 µl of DNA:liposome complex containing 15 µg of pUK21-C-VISA-BikDD, pUK21-CMV-BikDD, or pUK21-C-VISA (control), twice weekly for 3 consecutive weeks. The growth and metastasis of tumors were monitored in real time with the IVIS system, equipped with Living Imaging software (both from Xenogen). Tumor cell lines, such as Colo357FG and Colo357L3.6pl that do not contain a firefly luciferase gene and could not be detected by imaging with the IVIS system, were measured by wet tumor weight after the mice were sacrificed ( Figures 3E and S3 ).
Luciferase Assays
Forty-eight hours after the transient in vivo transfection, cells were subjected to lysis and assayed for luciferase activity with the dual-luciferase reporter assay system (Promega) according to the manufacturer's protocol (Xie et al., 2004) . To determine the tissue distribution of luciferase expression, mice were humanely killed by cervical dislocation, and their tumors and organs were dissected. Tissue specimens from tumors and major organs, including the pancreas, lung, heart, liver, spleen, kidney, brain, intestine, muscle, and ovary, were harvested and homogenized (Xie et al., 2004) . The luciferase activity in each cell lysate was measured with a luminometer (Lumat LB9507; Berthold Technologies, Bad Wildbad, Germany), and the protein concentration was determined (Xie et al., 2004) . The luminescence results were reported as relative light units per milligram of protein.
Histologic and Immunohistochemical Examinations
The pancreatic tumors and other tissues dissected from mice, as described in the previous section, were fixed overnight in 10% formaldehyde and transferred to 1:1 formaldehyde/ethanol for 1 hr; they were then transferred to 70% ethanol until processing. Tissues were processed in a series of increasing ethanol concentrations and embedded in paraffin wax. Five-micrometer sections were cut and stained with H&E. Immunostaining for firefly luciferase was also performed. Briefly, sections were deparaffinized in xylene, rehydrated in decreasing ethanol concentrations from 100% to 80%, and subjected to microwaving for 8 min in 10 mM citrate buffer (pH 6.0) at 95-99˚C for antigen retrieval; finally, endogenous peroxidase activity was quenched with 3% hydrogen peroxide. Nonspecific binding was abolished with 10% rabbit serum for 10 min. Tissue sections were incubated overnight at 4˚C with a 1:2000 dilution of 10 mg/ml goat anti-firefly luciferase antibody (Abcam, Hartford, CT). After being washed with PBS containing 0.1% Tween-20 for 2 hr, sections were incubated with horseradish peroxidaseconjugated avidin biotin complex (ABC) from the Vectastain Elite ABC Kit (Vector Laboratories, Inc., Burlingame, CA) for 45 min at room temperature. Peroxidase activity was revealed with AEC chromogen (Vector Laboratories) according to the protocol provided.
Finally, sections were washed in distilled water to terminate the reaction, counterstained with hematoxylin, dehydrated, and mounted.
In Vivo Apoptosis Assays
To identify cells undergoing apoptosis after induced BikDD expression, an in situ TUNEL assay (Promega) was performed according to the manufacturer's instructions. Tumor or tissue samples were fixed and sectioned as described in the previous section. After being rinsed with PBS, sectioned tumors or tissues were incubated in ice-cold permeabilization solution (0.1% Triton X-100, 0.1% sodium citrate) for 2 min at 0°C. Sectioned tumors or tissues were again rinsed with PBS and stained with TUNEL reaction mixture for 60 min at 37°C. After another washing with PBS, the sections were incubated with Converter-AP for 30 min at 37°C. Cells were rinsed and incubated with substrate BCIP/NTP (Promega) for 30 min. After a final PBS rinse, which was repeated once, the sections were microphotographed.
Analysis of Acute Toxic Effects Induced by Systemic Administration in Mice
C57BL/6 mice were studied for evidence of acute toxic effects induced by systemic administration of DNA:liposomal complexes. Mice were injected through a tail vein with 100 µl of a DNA:liposome complex at single doses of 2.5 mg/kg or 5 mg/kg body weight. Mouse morbidity and mortality and general condition were observed carefully. Mice were anesthetized and blood was collected by retro-orbital bleeding using a heparinized microcapillary tube. The mice were killed by CO 2 inhalation at the designated time points, and various organs were harvested for histopathologic examination.
To further evaluate the acute toxic effects on the pancreas, C57BL/6 mice were randomly divided into five groups. Group 1 was composed of negative control mice which were injected intraperitoneally with 0.9 % normal saline (NS) hourly for 7 intraperitoneal injections. Group 2 was composed of positive control mice intraperitoneally injected with cerulein (a cholecystokinin analogue; Sigma, St Louis, MO) hourly for 7 intraperitoneal injections at a dose of 50 µg/kg, to make an acute pancreatitis model. Groups 3, 4, and 5 were composed of the mice to be studied, which were injected through a tail vein with 100 µl of a DNA:liposome complex at single doses of 2.5 mg/kg body weight. Groups 1 and 2 mice were anesthetized and collected for blood by retro-orbital bleeding using a heparinized microcapillary tube 7 hours after injection of saline or cerulein according to the reports Sakaguchi et al., 2006) , whereas Group 3, 4 and 5 mice were anesthetized and collected for blood 2 days after treatment. Pancreas were removed immediately, frozen in liquid nitrogen, and stored at −80°C until assayed. Portions of these organs were also fixed in formaldehyde for histologic and TUNEL analysis.
Examination of Serum Chemistries and Pancreatic Trypsin Activity
Levels of serum AST, ALT, and BUN were measured at the biochemistry laboratory in the Department of Veterinary Medicine and Surgery. Serum amylase activity was determined using the Phadebas Amylase Test Kit (Magle Life Sciences, Lund, Sweden) following the manufacturers' instructions. To examine active trypsin in pancreatic tissue homogenates, the pancreatic tissue was homogenized on ice in a buffer containing 5 mM MES, 1 mM MgSO4, and
